Offering Guidance Through the Latest Science
on Lipid Conditions
The goal of this resource center is to be a practical tool that endocrinologists, other health care professionals, health-related organizations, and regulatory bodies can use to reduce the risks and consequences of dyslipidemia.
This resource center includes presentations that provide guidance on screening, risk assessment, and treatment recommendations for a range of individuals with various lipid disorders. The recommendations emphasize the importance of treating low-density lipoprotein cholesterol (LDL-C) in some individuals to lower goals than previously endorsed and support the measurement of coronary artery calcium scores and inflammatory markers to help stratify risk. Special consideration is given to individuals with diabetes, familial hypercholesterolemia, women, and youth with dyslipidemia. Both clinical and cost-effectiveness data are provided to support treatment decisions.
Chris K. Guerin, MD, FACE
Ex Officio & Chair, Lipids & CV Health Disease State Network:
Yehuda Handelsman, MD, FACP, MACE, FNLA
|Sergio Fazio, MD, PhD||John A. Tayek, MD|
|Eliot A. Brinton, MD, FAHA, FNLA||Ronald Krauss, MD|
|Kathleen Wyne, MD, PhD, FNLA, FACE||Victor Roberts, MD, MBA, FACP, FACE, ECNU|
|Paul D. Rosenblit, MD, PhD, FNLA, FACE||Scott Isaacs, MD, FACP, FACE|
|Paul S. Jellinger, MD, MACE||Brijendra Srivastava, MBBS, FRCP|
|David S. H. Bell, MD, FACP, FACE||Vijay Shivaswamy, MBBS|
|Ved Gossain, MD, FRCP, MACP, FACE||Chaitanya K. Mamillapalli, MD, MRCP|
|Eric Langer, DO, FACOI, FACE||Daniel Hurley, MD, FACE|
|Zachary T. Bloomgarden, MD, MACE|